PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50324C00015 — ATROPINE & PRALIDOXIME CHLORIDE INJECTOR, SINGLE DOSE AUTO-INJECTORS

ATROPINE & PRALIDOXIME CHLORIDE INJECTOR, SINGLE DOSE AUTO-INJECTORS is a federal NONE award for Department of Health and Human Services (HHS) held by MERIDIAN MEDICAL TECHNOLOGIES, LLC. Estimated value $82.2M ($82.2M obligated). Current period of performance ends Sep 29, 2026 (potential Sep 29, 2027). Last award drew 1 bidder.

$82.2M
Estimated Value
Sep 29, 2026
PoP End / Expires
1
Bidders (last award)

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

MERIDIAN MEDICAL TECHNOLOGIES, LLC holds $128.0M across 24 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 29, 2026 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

NONE
Contract number75A50324C00015
AgencyDepartment of Health and Human Services (HHS)
IncumbentMERIDIAN MEDICAL TECHNOLOGIES, LLC
UEIVBM4PLZ9VBC4
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC3650
PoP end (current)Sep 29, 2026
PoP end (w/ options)Sep 29, 2027
Obligated$82.2M

ATROPINE & PRALIDOXIME CHLORIDE INJECTOR, SINGLE DOSE AUTO-INJECTORS

Recompete timing

Public
Expiring in 44 days

Current PoP ends Sep 29, 2026 (44 days remaining). Agencies typically plan 12–18 months ahead — at 1.4 months out, that window is already open. The buying decision is likely already in motion.

Watch this contract — one email →

Incumbent footprint

Public record

MERIDIAN MEDICAL TECHNOLOGIES, LLC$128.0M obligated across 24 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($128.0M) · all agencies
Department of Health and Human Services (HHS)$92.6M · 72%
Department of State (DOS)$21.4M · 17%
Department of Defense (DOD)$13.9M · 11%
Environmental Protection Agency (EPA)$28K · 0%
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See the recompete window for 75A50324C00015
More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open MERIDIAN MEDICAL TECHNOLOGIES, LLC’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75A50324C00015?

75A50324C00015 (ATROPINE & PRALIDOXIME CHLORIDE INJECTOR, SINGLE DOSE AUTO-INJECTORS) is a Department of Health and Human Services (HHS) award with an estimated value of $82.2M, currently held by MERIDIAN MEDICAL TECHNOLOGIES, LLC. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75A50324C00015?

MERIDIAN MEDICAL TECHNOLOGIES, LLC is the incumbent with $128.0M across 24 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2026.

When does 75A50324C00015 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50324C00015